Le marché du traitement de l'anaphylaxie devrait atteindre 4 787,66 millions de dollars US en 2028 contre 2 664,66 millions de dollars US en 2021 ; on estime qu'il croîtra à un TCAC de 8,7 % au cours de la période 2021-2028.
L'anaphylaxie est une réaction allergique qui peut entraîner une maladie mortelle connue sous le nom de choc anaphylactique. L'anaphylaxie survient lorsque le corps du patient réagit à une substance étrangère et produit une grande quantité d'histamine qui déclenche une réaction inflammatoire. Selon l'Asthma and Allergy Foundation of America (AAFA), aux États-Unis, chaque année, il y a environ 200 000 visites à l'hôpital en raison d'allergies alimentaires. La croissance du marché du traitement de l'anaphylaxie est attribuée à des facteurs tels que l'incidence croissante de l'anaphylaxie et les récentes approbations de l'épinéphrine. Cependant, la faible accessibilité aux auto-injecteurs d'épinéphrine dans les pays à faible revenu entrave la croissance du marché.
Régions lucratives pour le marché du traitement de l'anaphylaxie
Aperçu du marché
Incidence croissante de l'anaphylaxie
L'anaphylaxie est une réaction allergique grave, potentiellement mortelle, causée par la vulnérabilité aux allergènes (aliments, piqûres d'insectes ou médicaments) identifiée comme un non-soi par un corps humain . Les signes typiques de cette affection comprennent des difficultés de déglutition et de respiration, des rougeurs et des démangeaisons cutanées, une accélération du rythme cardiaque, une respiration sifflante, une respiration rapide et une baisse de la tension artérielle. L'incidence de l'anaphylaxie augmente dans le monde entier. Selon le National Institute for Health and Care Excellence (NICE), l'anaphylaxie cause plus de 20 décès chaque année au Royaume-Uni. Selon les données de l'Académie européenne d'allergie et d'immunologie clinique, environ 150 millions d'Européens souffrent de maladies allergiques chroniques chaque année. Par conséquent, l'incidence croissante des allergies entraîne une augmentation des cas d'anaphylaxie. De plus, selon les faits sur les allergies de l'American College of Allergy, Asthma & Immunology, plus de 50 millions de personnes souffrent de différents types d'allergies chaque année.
1 à 15 % de la population américaine court le risque d'avoir une réaction anaphylactique lorsqu'elle est exposée à un ou plusieurs allergènes, et jusqu'à 1 % de ces patients meurent des suites d'une anaphylaxie. La condition entraîne environ 1 500 décès par an aux États-Unis; classent également les allergies au sixième rang des maladies chroniques. De plus, selon l'Asthma and Allergy Foundation of America (AAFA), en raison de l'augmentation des réactions allergiques alimentaires, le nombre de visites à l'hôpital a augmenté. Les allergies alimentaires sont la cause de plus de 200 000 visites aux urgences chaque année. Food Allergy Research & Education indique que plus de 32 millions d'Américains vivent avec des allergies alimentaires potentiellement mortelles. En raison de la prévalence croissante des allergies, la charge économique sur les systèmes de santé de nombreux pays augmente. Par exemple, selon Allergy Facts, le coût annuel de la gestion des cas d'allergies est de plus de 18 milliards de dollars américains aux États-Unis. Ainsi, l'incidence croissante de l'anaphylaxie stimule la croissance du marché.
Aperçus basés sur le type de médicament
En fonction du type de médicament, le marché du traitement de l'anaphylaxie est segmenté en épinéphrine, antihistaminiques, stéroïdes, bêta-agonistes et autres. Le segment de l'épinéphrine détenait la plus grande part du marché en 2020 et devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.
Marché du traitement de l'anaphylaxie, par type de médicament - 2020 et 2028
Informations basées sur la voie d'administration
En fonction de la voie d'administration, le marché du traitement de l'anaphylaxie est segmenté en administration orale, parentérale et autres. Le segment parentéral détenait la plus grande part du marché en 2020, tandis que le segment oral devrait enregistrer le TCAC le plus élevé de 8,9 % sur le marché au cours de la période de prévision.
Informations basées sur le type d'allergie
Selon le type d'allergie, le marché du traitement de l'anaphylaxie est segmenté en allergie alimentaire, médicaments, piqûres d'insectes et autres. Le segment des allergies alimentaires détenait la plus grande part du marché en 2020 et on estime qu'il a enregistré le TCAC le plus élevé du marché au cours de la période de prévision.
Insights basés sur les canaux de distribution
Basés sur canal de distribution, le marché du traitement de l'anaphylaxie est segmenté en pharmacies hospitalières, ventes au détail, courrier des pharmacies et autres. Le segment des ventes au détail détenait la plus grande part du marché en 2020 et on estime qu'il enregistrera le TCAC le plus élevé du marché au cours de la période de prévision.
Insights stratégiques
Les lancements et approbations de produits sont les stratégies couramment adoptées par les entreprises pour étendre leur empreinte mondiale et leurs portefeuilles de produits. De plus, les acteurs du marché du traitement de l'anaphylaxie se concentrent sur la stratégie de collaboration pour élargir leur clientèle, ce qui, à son tour, leur permet de maintenir leur marque à l'échelle mondiale.
Marché du traitement de l'anaphylaxie - par type de médicament
< ul>
Marché du traitement de l'anaphylaxie - par voie d'administration
- Oral
- Parentéral
- Autres
Marché du traitement de l'anaphylaxie - par type d'allergie
- Allergie alimentaire
- Médicaments
- Piqûres d'insectes
- Autres
- Pharmacies hospitalières
- Ventes au détail
- Autres
Anaphylaxie Marché du traitement - par géographie
- Amérique du Nord
- États-Unis
- Canada
- Mexique
- Europe
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne < li>Reste de l'Europe
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'Asie-Pacifique
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste du Moyen-Orient et Afrique
- Brésil
- Argentine
- Reste de l'Amérique du Sud et centrale
Profils des entreprises
- Amneal Pharmaceuticals Inc.
- Bioprojet
- Mylan NV
- Adamis Pharmaceutical Corporation
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELLé
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Anaphylaxis is an allergic reaction that can further lead to a fatal condition known as anaphylactic shock. Anaphylaxis occurs when the patient's body reacts to a foreign substance and produces a high amount of histamine that triggers an inflammatory response.
The growth of the anaphylaxis treatment market is attributed to the factors such as rising incidence of anaphylaxis, and recent approvals of epinephrine. Moreover, rise in cases of allergies post administration of covid-19 vaccines is also favoring the growth of the market
The anaphylaxis treatment market majorly consists of the players such as Amneal Pharmaceuticals Inc., Bioprojet, Mylan N.V., Adamis Pharmaceutical Corporation, Abbott, Pfizer Inc., Glaxosmithkline Plc., Merck And Co. Inc., Teva Pharmaceutical Industries Ltd., ALK-ABELLó among others.
The List of Companies - Anaphylaxis Treatment Market
- Amneal Pharmaceuticals Inc.
- Bioprojet
- Mylan N.V.
- Adamis Pharmaceutical Corporation
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.,
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELLó
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jun 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jun 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)